[{"id":"c39317e9-2ffe-4fe5-b487-781ec7511b8d","acronym":"","url":"https://clinicaltrials.gov/study/NCT02923180","created_at":"2021-01-18T14:21:11.868Z","updated_at":"2024-07-02T16:34:25.763Z","phase":"Phase 2","brief_title":"Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer","source_id_and_acronym":"NCT02923180","lead_sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","biomarkers":" AR • PD-1 • LAG3 • CD276 • HAVCR2 • TNFRSF9 • LAMP1","pipe":" | ","alterations":" CD276 expression • LAG3 expression • HAVCR2 expression • LAMP1 expression","tags":["AR • PD-1 • LAG3 • CD276 • HAVCR2 • TNFRSF9 • LAMP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD276 expression • LAG3 expression • HAVCR2 expression • LAMP1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e enoblituzumab (MGA271)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 33","initiation":"Initiation: 02/14/2017","start_date":" 02/14/2017","primary_txt":" Primary completion: 08/11/2020","primary_completion_date":" 08/11/2020","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2024-06-14"},{"id":"8d7085c4-b70c-4d81-8155-40e3a80cc9f5","acronym":"HEAT","url":"https://clinicaltrials.gov/study/NCT06014255","created_at":"2023-08-28T14:08:37.514Z","updated_at":"2024-07-02T16:34:27.119Z","phase":"Phase 2","brief_title":"Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer","source_id_and_acronym":"NCT06014255 - HEAT","lead_sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","biomarkers":" PD-1 • LAG3 • CD276 • TNFRSF9 • LAMP1","pipe":" | ","alterations":" PD-L1 expression • LAMP1 expression","tags":["PD-1 • LAG3 • CD276 • TNFRSF9 • LAMP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • LAMP1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e enoblituzumab (MGA271)"],"overall_status":"Recruiting","enrollment":" Enrollment 219","initiation":"Initiation: 02/16/2024","start_date":" 02/16/2024","primary_txt":" Primary completion: 03/01/2029","primary_completion_date":" 03/01/2029","study_txt":" Completion: 03/01/2029","study_completion_date":" 03/01/2029","last_update_posted":"2024-06-11"},{"id":"d5819f8b-eef3-4921-8ec5-7ad92269151b","acronym":"","url":"https://clinicaltrials.gov/study/NCT05634707","created_at":"2022-12-02T16:57:11.446Z","updated_at":"2024-07-02T16:35:18.987Z","phase":"Phase 1","brief_title":"Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)","source_id_and_acronym":"NCT05634707","lead_sponsor":"Duke University","biomarkers":" LAMP1","pipe":" | ","alterations":" LAMP1 expression • IDH wild-type","tags":["LAMP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LAMP1 expression • IDH wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • fluoxetine"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/05/2023","start_date":" 08/05/2023","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 06/01/2026","study_completion_date":" 06/01/2026","last_update_posted":"2024-02-19"},{"id":"0026d81a-cc97-48d8-bf24-2665e6d416d1","acronym":"","url":"https://clinicaltrials.gov/study/NCT03665571","created_at":"2021-05-03T11:02:25.289Z","updated_at":"2024-07-02T16:37:07.023Z","phase":"","brief_title":"Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer","source_id_and_acronym":"NCT03665571","lead_sponsor":"Asan Medical Center","biomarkers":" IFNG • LAMP1","pipe":" | ","alterations":" LAMP1 expression","tags":["IFNG • LAMP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LAMP1 expression"],"overall_status":"Unknown status","enrollment":" Enrollment 100","initiation":"Initiation: 07/01/2016","start_date":" 07/01/2016","primary_txt":" Primary completion: 10/01/2018","primary_completion_date":" 10/01/2018","study_txt":" Completion: 10/01/2019","study_completion_date":" 10/01/2019","last_update_posted":"2018-09-11"}]